EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tuning the Physical State of Aripiprazole by Mesoporous Silica

Daniel Kramarczyk iD, Justyna Knapik-Kowalczuk iD, Joanna Klimontko, Mateusz Kurek, Renata Jachowicz, Marian Paluch iD

Molecular Pharmaceutics · 2024

DOI: 10.1021/acs.molpharmaceut.3c01095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Daniel Kramarczyk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science and Technology, Institute of Physics, University of Silesia in Katowice, SMCEBI, 75 Pułku Piechoty 1a, 41-500 Chorzów, Poland. Hauptthemen laut MEDLINE: Aripiprazole, Silicon Dioxide, Calorimetry, Differential Scanning, Crystallization. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki, Uniwersytet Slaski w Katowicach.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main purpose of our studies is to demonstrate that commercially available mesoporous silica (MS) can be used to control the physical state of aripiprazole (ARP). The investigations performed utilizing differential scanning calorimetry and broadband dielectric spectroscopy reveal that silica can play different roles depending on its concentration in the system with amorphous ARP. At low MS content, it activates recrystallization of the active pharmaceutical ingredient and supports forming the III polymorphic form of ARP. At intermediate MS content (between ca. 27 and 65 wt %), MS works as a recrystallization inhibitor of ARP. At these concentrations, the formation of III polymorphic form is no longer favorable; therefore, it is possible to use this additive to obtain ARP in either IV or X polymorphic form. At the same time, employing MS in concentrations >65 wt % amorphous form of ARP with high physical stability can be obtained. Finally, regardless of the polymorphic form it crystallizes into, each composite is characterized by the same temperature dependence of relaxation times in the supercooled and glassy states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AripiprazoleSilicon DioxideCalorimetry, Differential ScanningCrystallizationPorosityDielectric SpectroscopyX-Ray Diffraction

Stichwörter der Autor:innen

amorphousaripiprazolephysical stabilitypolymorphismsilica materials

Substanzen

AripiprazoleSilicon Dioxide

Autor:innen und Institutionen

  • Faculty of Science and Technology, Institute of Physics, University of Silesia in Katowice, SMCEBI, 75 Pułku Piechoty 1a, 41-500 Chorzów, Poland.
  • Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, Jagiellonian University, Medyczna 9, 30-688 Kraków, Poland.

ORCID-Profile: Daniel Kramarczyk, Justyna Knapik-Kowalczuk, Marian Paluch

Förderung

  • Narodowe Centrum Nauki
  • Uniwersytet Slaski w Katowicach

Zitieren

APA

Kramarczyk, D., Knapik-Kowalczuk, J., Klimontko, J., Kurek, M., Jachowicz, R., & Paluch, M. (2024). Tuning the Physical State of Aripiprazole by Mesoporous Silica. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c01095

Vancouver

Kramarczyk D, Knapik-Kowalczuk J, Klimontko J, Kurek M, Jachowicz R, Paluch M. Tuning the Physical State of Aripiprazole by Mesoporous Silica. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.3c01095

BibTeX
@article{Kramarczyk2024,
  author = {Kramarczyk, Daniel and Knapik-Kowalczuk, Justyna and Klimontko, Joanna and Kurek, Mateusz and Jachowicz, Renata and Paluch, Marian},
  title = {Tuning the Physical State of Aripiprazole by Mesoporous Silica},
  journal = {Molecular Pharmaceutics},
  year = {2024},
  doi = {10.1021/acs.molpharmaceut.3c01095}
}
Kostenlos starten →